• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     HAYES, Inc. CMI magnetocardiograph model 2409 (CardioMag Imaging Inc.) for diagnosis of acute chest pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Virtual hysterosalpingograghy to evaluate the uterus and tubes patency]
2011     Committee for New Health Technology Assessment (CNHTA) [HBV entecavir resistance mutation [PCR-RFMP]]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2011     HAYES, Inc. Cooled radiofrequency denervation of the sacroiliac joint (pain management sInergy system, Baylis Medical Co. Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines and recommendations for ADHD in children and adolescents
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of the methodological instruments used in Health Technology Assessment
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Drug-eluting balloon for the treatment of coronary stenosis]
2011     HAYES, Inc. EsophyX system with srosaFuse fastener (EndoGastric Solutions) for endoluminal repair for gastroesophageal reflux disease (GERD)
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) Systematic review of economic evaluation on the use of PET-CT for cancer staging
2011     Committee for New Health Technology Assessment (CNHTA) [BRAF Gene, Mutation(Peptide Nucleic Acid Mediated Real-time PCR Clamping Method)]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Robotic gynecological surgery]
2011     HAYES, Inc. Exhaled breath condensate pH testing for asthma management
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Real time intraoperative magnetic resonance imaging monitoring]
2011     HAYES, Inc. Ex-PRESS glaucoma filtration device (Alcon Inc.) for treatment of primary open-angle glaucoma
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Multidisciplinary treatment programs for patients with non-malignant pain: a review of the clinical evidence, cost-effectiveness, and guidelines
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous acrylic vertebroplasty for the treatment of vertebral fractures]
2011     HAYES, Inc. eXtreme lateral interbody fusion (XLIF; NuVasive Inc.) for treatment of chronic low back pain
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain management: a review of clinical effectiveness, safety, and guidelines
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Dalfampridine (ampyra) in multiple sclerosis patients]
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness, and guidelines
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Training therapy in physical medicine – Systematic Review]
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) [Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2011     Committee for New Health Technology Assessment (CNHTA) [I-125 permanent implant for prostate cancer]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Microdebrider in nose-throat surgeries]
2011     HAYES, Inc. Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination therapy for pulmonary arterial hypertension: a review of the clinical effectiveness
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Exercise therapy (Krankengymnastik / Heilgymnastik) in physical medicine]
2011     Institute for Clinical and Economic Review (ICER) Management options for low back disorders
2011     Committee for New Health Technology Assessment (CNHTA) [Non-invasive cardiac output monitoring by bioreactance technology]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [The coblation technique in tonsillectomy]
2011     HAYES, Inc. Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2011     Committee for New Health Technology Assessment (CNHTA) [Enterovirus real-time rt-pcr]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab for pre-treated patients with advanced/metastatic melanoma
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Dabigatran and rivaroxaban as thrombophylaxis after major orthopedic surgery]
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in adults
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein test]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nilotinib (Tasigna) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Rational use of self-monitoring of blood glucose in type 1 diabetes]
2011     HAYES, Inc. Office-based phototherapy for treatment of atopic dermatitis in children
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Eliglustat tartrate, miglustat, imiglucerase, velaglucerase or a combination of these for the treatment of Gaucher disease: a review of clinical effectiveness and safety
2011     Committee for New Health Technology Assessment (CNHTA) [Deletion of 18q choromosome in colorectal cancer (LOH, loss of heterozygosity)]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cabazitaxel (Jevtana) for the second-line therapy of patients with hormone-refractory metastatic prostate cancer
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011     Committee for New Health Technology Assessment (CNHTA) [Photodynamic therapy for bladder, cervix and lung cancer]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Annual Report 2010. German version.]
2011     HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011     The Regional Health Technology Assessment Centre (HTA-centrum) [Surgical stabilization of a flail chest wall]
2011     Committee for New Health Technology Assessment (CNHTA) [C-11-acetate positron emission tomography, positron emission tomography/computed tomography]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annual Report 2010. English version
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011     HAYES, Inc. Provenge (Dendreon Corp.) vaccine for treatment of prostate cancer
2011     The Regional Health Technology Assessment Centre (HTA-centrum) [Active mobilization after flexor tendon repairs in zone II of the hand]
2011     Committee for New Health Technology Assessment (CNHTA) [Intraoperative Radiotherapy with Low Energy X-rays]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness
2011     HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for treatment of chronic sinusitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) IRay™ for wet age related macular degeneration
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in esophageal cancer
2011     Committee for New Health Technology Assessment (CNHTA) [Microvolt T-wave alternans system]
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dasatinib (Sprycel) for the first-line therapy of patients with newly diagnosed chronic phase philadelphia chromosome positive chronic myeloid leukemia.
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2011     HAYES, Inc. Sacroiliac joint fusion for treatment of adult low back pain
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in colorectal cancer
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diabetic foot ulcers - a health technology assessment]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-stress testing for pregnant adults with diabetes
2011     HAYES, Inc. Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dressing for patients undergoing hip or knee arthroplasty: clinical effectiveness and cost-effectiveness
2011     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drug eluting stents. What should be the indications for their use at the MUHC?
2011     National Institute for Health and Care Excellence (NICE) MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technologies guidance 8
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Alglucosidase alpha (Myozyme) for treatment of patients with late-onset Pompe disease]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011     HAYES, Inc. Tandem autologous peripheral blood stem cell transplantation for neuroblastoma
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines
2011     HAYES, Inc. Ultroid hemorrhoid management system (Ultroid Technologies Inc.)
2011     Basque Office for Health Technology Assessment (OSTEBA) [Genetics development plan in the Basque Country]
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Brain injury rehabilitation - a health technology assessment]
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac output monitors to assess patient resuscitation needs: a review of clinical effectiveness and cost-effectiveness
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel, Prasugrel and Ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Nurse-endoscopy of the colon; a randomized trial on accuracy, patient experiences and costs]
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Antipsychotic polypharmacy in the treatment of schizophrenia]